- Home
- MOD vs NUVL Comparison
MOD vs NUVL Comparison
Compare MOD & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOD
- NUVL
- Stock Information
- Founded
- MOD 1916
- NUVL 2017
- Country
- MOD United States
- NUVL United States
- Employees
- MOD N/A
- NUVL N/A
- Industry
- MOD Auto Parts:O.E.M.
- NUVL Biotechnology: Pharmaceutical Preparations
- Sector
- MOD Consumer Discretionary
- NUVL Health Care
- Exchange
- MOD Nasdaq
- NUVL Nasdaq
- Market Cap
- MOD 4.9B
- NUVL 5.5B
- IPO Year
- MOD N/A
- NUVL 2021
- Fundamental
- Price
- MOD $99.52
- NUVL $81.20
- Analyst Decision
- MOD Strong Buy
- NUVL Strong Buy
- Analyst Count
- MOD 5
- NUVL 10
- Target Price
- MOD $135.50
- NUVL $119.60
- AVG Volume (30 Days)
- MOD 835.8K
- NUVL 593.3K
- Earning Date
- MOD 07-29-2025
- NUVL 08-07-2025
- Dividend Yield
- MOD N/A
- NUVL N/A
- EPS Growth
- MOD 12.87
- NUVL N/A
- EPS
- MOD 3.42
- NUVL N/A
- Revenue
- MOD $2,583,500,000.00
- NUVL N/A
- Revenue This Year
- MOD $6.68
- NUVL N/A
- Revenue Next Year
- MOD $9.36
- NUVL N/A
- P/E Ratio
- MOD $28.83
- NUVL N/A
- Revenue Growth
- MOD 7.30
- NUVL N/A
- 52 Week Low
- MOD $64.79
- NUVL $55.54
- 52 Week High
- MOD $146.84
- NUVL $113.51
- Technical
- Relative Strength Index (RSI)
- MOD 54.33
- NUVL 59.81
- Support Level
- MOD $97.87
- NUVL $77.21
- Resistance Level
- MOD $105.54
- NUVL $81.00
- Average True Range (ATR)
- MOD 3.61
- NUVL 2.63
- MACD
- MOD -0.11
- NUVL 0.13
- Stochastic Oscillator
- MOD 53.70
- NUVL 90.63
About MOD Modine Manufacturing Company
Modine Manufacturing Co provides thermal management solutions to diversified markets and customers. The company provides engineered heat transfer systems and heat transfer components for use in on- and off-highway original equipment manufacturer (OEM) vehicular applications in the United States. It offers powertrain cooling products, such as engine cooling assemblies, radiators, condensers, and charge air coolers; auxiliary cooling products, including power steering and transmission oil coolers. Its operating segments include Climate Solutions and Performance Technologies.
About NUVL Nuvalent Inc.
Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically proven kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.